Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PLXPQ similar filings
- 12 Jun 17 PLx Pharma Inc. Announces Pricing of Registered Direct Offering
- 5 May 17 Regulation FD Disclosure
- 2 May 17 Rita M. O’Connor Appointed Chief Financial Officer of PLx Pharma
- 20 Apr 17 PLx Pharma and Dipexium Pharmaceuticals Complete Merger
- 22 Dec 16 Dipexium and PLx Pharma Announce Merger Agreement
- 14 Dec 16 Departure of Directors or Certain Officers
- 16 Nov 16 Departure of Directors or Certain Officers
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Dipexium Pharmaceuticals, Inc.’s Registration Statements on Form S-3 (No. 333-204830) and Form S-8 (No. 333-196824 and 333-212421) of our report dated January 17, 2017 relating to the consolidated financial statements of PLx Pharma, Inc. as of December 31, 2016 and 2015 and the years then ended included in this Current Report on Form 8-K.
/s/ GBH CPAs, PC
GBH CPAs, PC
www.gbhcpas.com
Houston, Texas
April 19, 2017